S. G. Berrak Et Al. , "A double-blind, crossover, randomized dose-comparison trial of granisetron for the prevention of acute and delayed nausea and emesis in children receiving moderately emetogenic carboplatin-based chemotherapy," SUPPORTIVE CARE IN CANCER , vol.15, no.10, pp.1163-1168, 2007
Berrak, S. G. Et Al. 2007. A double-blind, crossover, randomized dose-comparison trial of granisetron for the prevention of acute and delayed nausea and emesis in children receiving moderately emetogenic carboplatin-based chemotherapy. SUPPORTIVE CARE IN CANCER , vol.15, no.10 , 1163-1168.
Berrak, S. G., Ozdemir, N., Bakirci, N., Turkkan, E., Canpolat, C., Beker, B., ... Yoruk, A.(2007). A double-blind, crossover, randomized dose-comparison trial of granisetron for the prevention of acute and delayed nausea and emesis in children receiving moderately emetogenic carboplatin-based chemotherapy. SUPPORTIVE CARE IN CANCER , vol.15, no.10, 1163-1168.
Berrak, Su Et Al. "A double-blind, crossover, randomized dose-comparison trial of granisetron for the prevention of acute and delayed nausea and emesis in children receiving moderately emetogenic carboplatin-based chemotherapy," SUPPORTIVE CARE IN CANCER , vol.15, no.10, 1163-1168, 2007
Berrak, Su G. Et Al. "A double-blind, crossover, randomized dose-comparison trial of granisetron for the prevention of acute and delayed nausea and emesis in children receiving moderately emetogenic carboplatin-based chemotherapy." SUPPORTIVE CARE IN CANCER , vol.15, no.10, pp.1163-1168, 2007
Berrak, S. G. Et Al. (2007) . "A double-blind, crossover, randomized dose-comparison trial of granisetron for the prevention of acute and delayed nausea and emesis in children receiving moderately emetogenic carboplatin-based chemotherapy." SUPPORTIVE CARE IN CANCER , vol.15, no.10, pp.1163-1168.
@article{article, author={Su G. Berrak Et Al. }, title={A double-blind, crossover, randomized dose-comparison trial of granisetron for the prevention of acute and delayed nausea and emesis in children receiving moderately emetogenic carboplatin-based chemotherapy}, journal={SUPPORTIVE CARE IN CANCER}, year=2007, pages={1163-1168} }